Literature DB >> 15463375

The immune recognition of malaria antigens.

E M Riley1, O Olerup, M Troye-Blomberg.   

Abstract

Owing to the demonstration that the immune response of inbred mice to some defined malaria antigens is influenced by the major histocompatibility complex (MHC), and the finding that only a minority of individuals living in malaria-endemic areas appear to recognize such antigens, there are fears that synthetic subunit malaria vaccines will be poorly immunogenic in a substantial proportion of the target population. Such fears have been reinforced by the results of the first two human malaria vaccine trials. In this review Eleanor Riley, Olle Olerup and Marita Troye-Blomberg summarize the experimental evidence for MHC-related genetic restriction of malaria immunity and discuss some alternative explanations for nonresponsiveness in populations living in malaria-endemic areas.

Entities:  

Year:  1991        PMID: 15463375     DOI: 10.1016/0169-4758(91)90076-z

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  4 in total

1.  Identification and characterization of Neospora caninum cyclophilin that elicits gamma interferon production.

Authors:  Wenbin Tuo; Raymond Fetterer; Mark Jenkins; J P Dubey
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  HLA-DR and -DQ gene polymorphism in West Africans is twice as extensive as in north European Caucasians: evolutionary implications.

Authors:  O Olerup; M Troye-Blomberg; G M Schreuder; E M Riley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  Exploiting structural differences among heteroduplex molecules to simplify genotyping the DQA1 and DQB1 alleles in human lymphocyte typing.

Authors:  P A Zimmerman; M N Carrington; T B Nutman
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

Review 4.  Infectious diseases and immunity: special reference to major histocompatibility complex.

Authors:  N Singh; S Agrawal; A K Rastogi
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.